These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30904494)

  • 1. Structural insights on druggable hotspots in CD147: A bull's eye view.
    Kumar D; Vetrivel U; Parameswaran S; Subramanian KK
    Life Sci; 2019 May; 224():76-87. PubMed ID: 30904494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD147 (EMMPRIN/Basigin) in Tissue Remodeling.
    Guindolet D; Gabison EE
    Anat Rec (Hoboken); 2020 Jun; 303(6):1584-1589. PubMed ID: 30768865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repressing CD147 is a novel therapeutic strategy for malignant melanoma.
    Hu X; Su J; Zhou Y; Xie X; Peng C; Yuan Z; Chen X
    Oncotarget; 2017 Apr; 8(15):25806-25813. PubMed ID: 28445958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity.
    Grass GD; Toole BP
    Biosci Rep; 2015 Nov; 36(1):e00283. PubMed ID: 26604323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis.
    Xin X; Zeng X; Gu H; Li M; Tan H; Jin Z; Hua T; Shi R; Wang H
    Sci Rep; 2016 Sep; 6():32804. PubMed ID: 27608940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological Characteristics of Cluster of Differentiation 147 and Its Relationship with Tumour.
    Gao C; Lu CH; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):589-593. PubMed ID: 27825419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of N-glycosylation on CD147 for its biological functions.
    Bai Y; Huang W; Ma LT; Jiang JL; Chen ZN
    Int J Mol Sci; 2014 Apr; 15(4):6356-77. PubMed ID: 24739808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature.
    Xiong L; Edwards CK; Zhou L
    Int J Mol Sci; 2014 Sep; 15(10):17411-41. PubMed ID: 25268615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD147 immunoglobulin superfamily receptor function and role in pathology.
    Iacono KT; Brown AL; Greene MI; Saouaf SJ
    Exp Mol Pathol; 2007 Dec; 83(3):283-95. PubMed ID: 17945211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer.
    Hao JL; Cozzi PJ; Khatri A; Power CA; Li Y
    Curr Cancer Drug Targets; 2010 May; 10(3):287-306. PubMed ID: 20370680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic fragment of CD147 generated by regulated intramembrane proteolysis contributes to HCC by promoting autophagy.
    Wu B; Cui J; Yang XM; Liu ZY; Song F; Li L; Jiang JL; Chen ZN
    Cell Death Dis; 2017 Jul; 8(7):e2925. PubMed ID: 28703811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dealing with the family: CD147 interactions with cyclophilins.
    Yurchenko V; Constant S; Bukrinsky M
    Immunology; 2006 Mar; 117(3):301-9. PubMed ID: 16476049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts.
    Abraham D; Zins K; Sioud M; Lucas T; Aharinejad S
    Front Biosci; 2008 May; 13():5571-9. PubMed ID: 18508606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease.
    von Ungern-Sternberg SNI; Zernecke A; Seizer P
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters.
    Li X; Yu X; Dai D; Song X; Xu W
    Oncotarget; 2016 Apr; 7(17):23141-55. PubMed ID: 27009812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD147: a novel modulator of inflammatory and immune disorders.
    Zhu X; Song Z; Zhang S; Nanda A; Li G
    Curr Med Chem; 2014; 21(19):2138-45. PubMed ID: 24372217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis.
    Zhang Z; Yang X; Zhang H; Liu X; Pan S; Li C
    J Periodontal Res; 2018 Jun; 53(3):391-402. PubMed ID: 29315565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of extracellular matrix metalloproteinase inducer/CD147 in gastrointestinal cancer: a meta-analysis of related studies.
    Huang X; Shen W; Xi H; Zhang K; Cui J; Wei B; Chen L
    Oncotarget; 2016 Dec; 7(49):81003-81011. PubMed ID: 27768590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference targeting CD147 inhibits metastasis and invasion of human breast cancer MCF-7 cells by downregulating MMP-9/VEGF expression.
    Li F; Zhang J; Guo J; Jia Y; Han Y; Wang Z
    Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):676-684. PubMed ID: 29901696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpoint.
    Kosugi T; Maeda K; Sato W; Maruyama S; Kadomatsu K
    Nephrol Dial Transplant; 2015 Jul; 30(7):1097-103. PubMed ID: 25248362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.